Tuesday, 23 Jan 2018

Drug Safety

Datesort ascending Type Title Save
29 Dec 2017 Social Tramadol dosing: max is 400 mg/d. For those >75 yrs, the max is 300 mg/d; those w/ CKD (<30 mL/min) max dose=200 mg/d https://t.co/vfIlshFX0m
29 Dec 2017 Social laims data on RA pts shows better persistence w/ MOA switchers vs TNFi cyclers (48% v 40%) & lower healthcare costs https://t.co/T8hgx8kbpj
28 Dec 2017 Social FDA Safety Alert onFEBUXOSTAT and increased risk of Cardiac Death (compared to allopurinol). Based on 6000 pt safety trial, Febuxostat shows increased risk of CV deaths & death from all causes. https://t.co/4WtQ8FHK4g
26 Dec 2017 Social RHeumNow Week in Review is up! listen here https://t.co/2wJvceeBOB or watch here https://t.co/gBz1Pimrjg Happy Merry Christmas to all !
22 Dec 2017 Social France fines J&J 25 million euros over painkiller patch Duragesic, for disparaging generic competition https://t.co/UjccBaN2Uf
20 Dec 2017 Social Check out Kathryn Dao's #ACR17 video review of the FDA Safety symposia at the ACR! https://t.co/5cK1wuuGQF
20 Dec 2017 Social FDA has studyied the safety of Gadolinium-based Contrast Agents (GBCAs)since 7/15 & now rewarns HCPs to limit GBCA to circumstances where a contrast agent is necessary & limit use of repetitive MRI w/ GBCAs https://t.co/ckEuDsJEUD
20 Dec 2017 Social The problem of nonadherence to meds, not filling Prescriptions is a big one. NYT reviews it stating that the only promising solution is cheaper meds https://t.co/tSEbH54Dt3
19 Dec 2017 Social High Costs of FDA Approval for Formerly Unapproved Marketed Drugs #medicine #feedly https://t.co/502dMIJ4wu
18 Dec 2017 News Baseline Risk Score Predicts Serious Infection Risk in TNF-Treated RA Patients
18 Dec 2017 News Advantages of Intravenous Pulse Cyclophosphamide in ANCA-associated Vasculitis
17 Dec 2017 Social Sanofi recalls SYNVISC-One, specifically one batch of ~12,000 plus distributed between Oct. 25 -Nov. 7, 2017 only in the USA https://t.co/3f4ocIoEEl
17 Dec 2017 Social RT @TaraCortes: An Overlooked Epidemic: Older Americans Taking Too Many Unneeded Drugs https://t.co/n82hkTdO3V via @khnews
16 Dec 2017 Social RheumNow Wk in Review is Up! Cush reviews UK GCA turndown, FUO Dx by FDG-PET, Novel ABA results, Sjogrens STAT3 story. https://t.co/FCUQ9lCSvo https://t.co/fR7Zf3b7UG
14 Dec 2017 Social NICE and NHS reject the approval of Tocilizumab for use in GCA citing cost concerns https://t.co/TZMmnj91sp https://t.co/aQMFLKVCYo
12 Dec 2017 Social RT @StefanSiebert1: JAK inhibitors and thrombotic events - especially pulmonary. Review of FDA safety data https://t.co/yZgYfzOwV1 with exc…
08 Dec 2017 Social RT @FDA_Drug_Info: #FDA again approved more generics in a single month than ever before, 107 in Nov. 2017, improving access to affordable d…
05 Dec 2017 Social FDA grants orphan drug designation to SER-287 a microbiome drug to treat dysbiosis of pediatric ulcerative colitis. Will microbiome targeted therapies be the next (safe) best thing? https://t.co/PmOLeyLyy3
01 Dec 2017 Social Taltz (ixekizumab), the IL-17 inhibitor from Lilly, is FDA Approved for use in Active Psoriatic Arthritis, based on… https://t.co/dY4tQNqfcC
29 Nov 2017 Social FDA approves Fasenra (benralizumab) that binds to the IL-5α receptor, and depletes eosinophils rapidly. Indicated… https://t.co/2CD3qhAzvO